Abstract
Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy, which is one of the potential life-threatening complications of pregnancy. Peripartum cardiomyopathy is observed between the last 4 weeks of the pregnancy and the postpartum 5th month. It is related to high rate of maternal and infant mortality. Although the underlying factor has not been clearly understood yet, many factors such as infections, myocarditis, immunological factors or oxidative stress caused by prolactin have been attributed. We aimed to discuss the emergency management of postpartum PPCM in our case report.
Keywords
References
- Doğan R, Gülbay BE, Kaya A, Saryal S, Acıcan T. Postpartum dönemde gelişen akut solunum yetmezliğinde ayırıcı tanı. Yoğun Bakım Dergisi 2002;2(2):136-140.
- Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(2):207-221.
- Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM):EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 2017.
- Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;364:k5287.
- Cunningham FG, Byrne JJ, Nelson DB. Peripartum cardiomyopathy. Obstet Gynecol. 2019;133(1):167-179.
- Koenig T, Hilfiker-Kleiner D, Bauersachs J. Peripartum cardiomyopathy. Herz. 2018;43(5):431-437.
- Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971;44:964-968.
- Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016;133:1397–1409.
- McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015;66: 905–914.
Abstract
Peripartum kardiyomiyopati (PPKM), gebeliğin potansiyel olarak hayati tehlike arz eden komplikasyonlarından olarak bir dilate kardiyomiyopati formudur. PPKM, gebeliğin son 4 haftası ve postpartum 5. aylar arasında görülmektedir. PPKM yüksek anne ve bebek mortalitesi ile ilişkilidir. Altta yatan kesin neden belli olmamakla birlikte enfeksiyonlar, myokardit, immünolojik faktörler, prolaktinin neden olduğu oksidatif stres gibi birçok neden suçlanmaktadır. Olgu sunumumuzda postpartum gelişen PPKM olgusunun acil yönetimini tartışmayı amaçladık.
Keywords
References
- Doğan R, Gülbay BE, Kaya A, Saryal S, Acıcan T. Postpartum dönemde gelişen akut solunum yetmezliğinde ayırıcı tanı. Yoğun Bakım Dergisi 2002;2(2):136-140.
- Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(2):207-221.
- Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM):EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 2017.
- Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;364:k5287.
- Cunningham FG, Byrne JJ, Nelson DB. Peripartum cardiomyopathy. Obstet Gynecol. 2019;133(1):167-179.
- Koenig T, Hilfiker-Kleiner D, Bauersachs J. Peripartum cardiomyopathy. Herz. 2018;43(5):431-437.
- Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971;44:964-968.
- Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016;133:1397–1409.
- McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015;66: 905–914.
Details
| Primary Language | English |
|---|---|
| Subjects | Emergency Medicine |
| Journal Section | Case Reports |
| Authors | |
| Publication Date | March 1, 2022 |
| Submission Date | September 13, 2021 |
| Acceptance Date | October 5, 2021 |
| Published in Issue | Year 2022 Volume: 4 Issue: 1 |
Phoenix Medical Journal is licensed under a Creative Commons Attribution 4.0 International License.
Phoenix Medical Journal has signed the Budapest Open Access Declaration.